Newest sarms ACP105 / SARMS / ACP-105 / acp 105 new product
1. ACP105 description:
Product Specification : 98%
Minmum Order Quantity : >50g
Sample Requirement : Free Sample / Freight Charged / to final
Product No.: PURACP
2. ACP105 COA:
|Appearance||A white crystalline powder|
|Loss on drying||NMT0.5%||0.07%|
|Assay(On dry basis)||99.0%-101.0%||99.58%|
|Microbiology||Total bacterial count:<1000CFU/g||30CFU/g|
|Total Fungus count: <100CFU/g||<10 CFU/g|
|Escherichia coli:Not detected||Not detected|
3. ACP-105, a Novel Non-Steroidal SARM:
In a poster presentation titled, "In Vitro and In Vivo Profile of a
Novel Tissue Selective, Orally Bioavailable Non-Steroidal Androgen
Receptor Modulator," ACADIA researchers present findings on
ACP-105, a novel non-steroidal SARM.ACP-105 is shown to be as
potent and efficacious as testosterone in in vitro assays without
interaction at other hormone receptors. In addition, ACP-105
demonstrates potent anabolic effects on muscle and bone with
minimal effect on prostrate in preclinical models.
4. About ACP-105:
ACP-105 is a non-steroidal and selective androgen receptor agonist.
ACP-105 is part of a class of molecules referred to as selective
androgen receptor modulators (SARMs). SARMs may advance the
standard of treatment for a variety of disorders including
muscle-wasting conditions and osteoporosis, with fewer side effects
as compared to current treatments based on testosterone
replacement. ACP-105 has exhibited promising pharmacological
properties and a favorable safety profile in preclinical testing.
5. ACP105 Function:
Anabolism - promotion and growth of lean muscle tissue and mass.
This is extremely important for the individual suffering from a
muscle wasting disease. It is the muscle wasting that at times can
lead to the demise of the patient even before the disease itself.
Increases in strength - again, excellent for those suffering from muscle wasting
Increased bone density and strength - highly beneficial to the
osteoporosis patient. SARMS may prove to be one of if not the most
effective osteoporosis treatments available, although official data
is still inconclusive.
Fat Loss - medications with strong androgen binding affinity have been
shown to promote lipolysis. How significant these six SARMS are in
this regard is inconclusive.
Low to No Virilization - this is highly important to women. Many compounds
(anabolicandrogenic steroids) while the same benefits of anabolic
steroids can apply to women as they do men, there is often the
issue of virilization. Virilization refers to the promotion of
masculine like traits in women, i.e. body hair growth, a deepening
of the vocal chords and clitoral enlargement. SARMS have been shown
to NOT promote virilization symptoms in women. Existing data
supports that the pre-clinical SARMS should be no different,
although again at this stage is not fully conclusive.
Increased Libido (Females) - preliminary data, especially in regards to AC-262,356 has shown
the SARM may increase female libido significantly.
Contraceptive (Males) - preliminary data, especially in regards to S-23 has shown the
SARM may be an effective male contraceptive.
Endurance & Conditioning - All of the pre-clinical SARMS should have a level of positive
effect on muscular endurance as well as overall physical
conditioning. The level of effectiveness in such regards is
dependent on the SARM in question and data is still inconclusive to
quantify the total effects.
Nutrient Efficiency - All of the pre-clinical SARMS should have a positive impact on
nutrient efficiency to one degree or another. This refers to the
ability of the body to make better use of the nutrients it
Estrogen and DHT - The pre-clinical SARMS should not aromatize, referring to the
promotion of the testosterone to estrogen conversion. However, some
increases in serum estrogen levels may be possible depending on the
SARM. Dihydrotestosterone (DHT) related side effects (hair loss,
acne) are also not possible with these SARMS. There should also be
little to no negative affect on the prostate; in fact, data shows
potential prostate health improvement.